Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNABII family DNA-binding proteins, primarily comprising Integration Host Factor (IHF) and Histone-like protein (HU), are ubiquitous bacterial proteins that play essential roles in both intracellular genetic regulation and extracellular biofilm stability [1, 6]. Intracellularly, they function as nucleoid-associated proteins (NAPs) that bind and bend DNA to facilitate replication, recombination, and transcription [4, 6]. Extracellularly, these proteins serve as critical structural "linchpins" within the extracellular polymeric substance (EPS), where they stabilize the lattice of extracellular DNA (eDNA) by binding to crossed DNA strands at vertices [1, 8]. This stabilization maintains the structural integrity of mature biofilms, protecting resident bacteria from host immune responses and making them highly resistant to conventional antibiotic therapy [2, 3]. Therapeutic strategies, such as the monoclonal antibody cocktail CMTX-101, target the conserved DNA-binding regions of these proteins to sequester them from the biofilm matrix [3, 8]. This sequestration leads to the rapid collapse of the biofilm architecture, releasing the bacteria and significantly increasing their susceptibility to antibiotics and innate immune clearance [7, 8].
Sequestration of DNABII proteins from the biofilm matrix, leading to the collapse of the extracellular DNA lattice and sensitization of bacteria to antibiotics and immune clearance.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNABII family DNA-binding proteins (DNABII).